ClinConnect ClinConnect Logo
Search / Trial NCT06689878

Mobile Cognitive Behavioral Therapy for Stroke

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Nov 13, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Stroke Recovery Stroke Rehabilitation Cognitive Behavioral Therapy Cbt

ClinConnect Summary

This clinical trial is looking at a mobile app called "MAYA" that offers cognitive behavioral therapy (CBT) to help adults who have had a stroke and are dealing with anxiety and depression. The goal is to see if using this app is a good option for people who need support for their mental health after a stroke. The study is currently recruiting participants aged 40 to 79 who have experienced a stroke at least a month ago and are facing significant anxiety or depression.

To participate, individuals should be able to use an iPhone or iPad and have internet access at home. They should also be stable on any medication for anxiety or depression for at least eight weeks before joining. The study will involve using the app over a certain period, and participants will be expected to engage fully in the study. It's important for potential participants to know that there are certain conditions that would make them ineligible, such as severe depression or a history of certain mental health disorders. If you or a loved one is interested in this study, it could be a promising opportunity to explore new ways to manage mental health after a stroke.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 40-79
  • Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
  • Stroke that occurred 1 month or more prior to study initiation
  • Capacity to provide consent
  • No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
  • If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation
  • Ability to use iPhone or iPad independently
  • Home internet access
  • Willingness to participate in the full study duration.
  • Exclusion Criteria:
  • Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
  • Non-fluency in English
  • History of a bipolar or psychotic disorder
  • Current alcohol or substance use disorder
  • Active suicidal ideation
  • Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
  • Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services
  • Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant

About Weill Medical College Of Cornell University

Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Abhishek Jaywant, PhD

Principal Investigator

Weill Medical College of Cornell University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported